Fig. 2From: Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospectsIllustrative diagram with the relevant mechanisms of repurposing anthelmintic drugs in cancer therapy. Symbols: ↑increase, ↓decrease. Bcl-2 B-cell lymphoma 2, ROS reactive oxygen species, Wnt Wingless-related integration site, XIAP X-linked inhibitor of apoptosis proteinBack to article page